A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/08/2004	EP1483384A2 Method for overexpression of zwitterionic polysaccharides
12/08/2004	EP1483380A2 Recombinant protein c variants
12/08/2004	EP1483366A1 Antimicrobial composition
12/08/2004	EP1483298A2 Materials and methods for preparing dimeric growth factors
12/08/2004	EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
12/08/2004	EP1483290A2 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1483286A1 A process for the production of ramoplanin-like amide derivatives
12/08/2004	EP1483285A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME
12/08/2004	EP1483284A2 Selective dipeptide inhibitors of kallikrein
12/08/2004	EP1483283A1 Modulation of protein methylation and phosphoprotein phosphate
12/08/2004	EP1483023A1 Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
12/08/2004	EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES
12/08/2004	EP1482986A1 Method for determining effect of a clostridial toxin upon a muscle
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482982A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof
12/08/2004	EP1482981A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
12/08/2004	EP1482978A1 Pharmaceutical composition comprising osteoclastogenesis inhibitory factor
12/08/2004	EP1482976A1 A preparation and method for weight reduction
12/08/2004	EP1482975A2 Prevention of tissue adhesion
12/08/2004	EP1482974A2 Electroporation methods for introducing bioactive agents into cells
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482969A2 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/08/2004	EP1482968A2 Treatment of type i diabetes mellitus using growth hormone antagonist
12/08/2004	EP1482967A1 Pharmaceutical and cosmetic compositions comprising plgf-1
12/08/2004	EP1482966A1 Method and composition for treating skin wounds with epidermal growth factor
12/08/2004	EP1482965A2 Method to control tumor progression and invasiveness
12/08/2004	EP1482964A1 Use of egfr transactivation inhibitors in human cancer
12/08/2004	EP1482963A2 Controlled modulation of amino acid side chain length of peptide antigens
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482961A2 Use of soluble fgl2 as an immunosuppressant
12/08/2004	EP1482960A2 Methods and products for oral care
12/08/2004	EP1482952A2 Therapeutic and prophylactic treatment of aging and disorders of aging in humans
12/08/2004	EP1482894A2 Cosmetic formulations containing l-arginine oligomers
12/08/2004	EP1482858A2 Methods for aneurysm repair
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1404378A4 Methods and apparatus relating to treatment systems using light for the treatment of fluid products
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1303290A4 Small peptides and methods for downregulation of ige
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1220693B1 Formulations for delivery of osteogenic proteins
12/08/2004	EP1168934A4 Hydrogel-forming system with hydrophobic and hydrophilic components
12/08/2004	EP1143797A4 Methods for reducing adverse side effects associated with cellular transplantation
12/08/2004	EP1141014B1 Insulin-like growth factor (igf) i mutant variant
12/08/2004	EP1125135B1 A complex of a chaperone with beta-amyloid and methods employing this complex
12/08/2004	EP1121369B1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
12/08/2004	EP1045858B1 Anti-cryptococcal peptides
12/08/2004	EP1015015A4 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	EP0966535B1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/08/2004	EP0863729B1 Implantable controlled release device to deliver drugs directly to an internal portion of the body
12/08/2004	EP0833941A4 Polypeptides having a functional domain of interest and methods of identifying and using same
12/08/2004	EP0575432B1 Modified proteins and their use for controlling viral infections
12/08/2004	CN1553963A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/08/2004	CN1553958A Photochemical internalization for delivery of molecules into the cytosol
12/08/2004	CN1553955A Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof
12/08/2004	CN1553952A Materials and methods to promote repair of nerve tissue
12/08/2004	CN1553897A Dolastatin 10 derivatives
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553817A Method for improving oxygen transport by stored red blood cells
12/08/2004	CN1553811A Human tissue urokinase type plasminogen activator formulation
12/08/2004	CN1553810A Use of HCG and LH in controlled ovarian hyperstimulation
12/08/2004	CN1553809A Use of LH in controlled ovarian hyperstimulation
12/08/2004	CN1553808A Use of HCG in controlled ovarian hyperstimulation
12/08/2004	CN1553807A Compositions comprising mixtures of therapeutic proteins and methods of producing the same
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553805A Nutritional compositions for controlling blood glucose level
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1552894A Corn peptide and its preparation and use
12/08/2004	CN1552892A Physiological active buck peptide by compound proteinase catalysis and use of products thereby
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552850A Recombined human gama interferon gland virus and preparation of products therefrom
12/08/2004	CN1552845A Cheese lactobacillus Bd-II strain and use for decreasing blood fat
12/08/2004	CN1552734A Recombination glant associated virus carrier induced TNF concerned cytonecrosis ligand peptide segment and its use
12/08/2004	CN1552733A Preparation of myocardium peptide
12/08/2004	CN1552731A Use and clone expression of coronavirus phosphorylated nucleoprotein of SARS
12/08/2004	CN1552727A Targetted polypeptide for specificity of liver cancer blood vessel
12/08/2004	CN1552445A Medicinal preparation for preventing from pyloric helicobacterium inflammation
12/08/2004	CN1552444A Amino acid containing human milk and superoxide dismutase composition and its preparation
12/08/2004	CN1552443A Lysozyme injection preparation
12/08/2004	CN1552442A Interferon nasal spray powder with long service for detoxication and anti-bacteria
12/08/2004	CN1552441A Sterilizing and antibacterial interferon oral cavity paster
12/08/2004	CN1552440A Removing albumin nerve growth factor agent
12/08/2004	CN1552439A Myocardium peptide and its use
12/08/2004	CN1552438A Medicine for decreasing vagina acidity and treating vaginitis, use thereof
12/08/2004	CN1552417A Extracts and use of Leimo
12/08/2004	CN1552310A Preparation of powder agglomerates
12/08/2004	CN1179041C Improved phytases
12/08/2004	CN1179037C Bacillus substilis Var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
12/08/2004	CN1178956C Cancer antigens based on tumor suppressor gene WT1 product
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178954C Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/08/2004	CN1178950C Corpuscles of stannius protein and stanniocalcin
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178696C Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
12/08/2004	CN1178695C Oxidized thymosin beta 4
12/08/2004	CN1178694C Use of IL-12 and IFN-'alpha' for treatment of infectiong diseases
12/08/2004	CN1178693C Preparation method for earthworm antibacterial peptide

1 ... 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 ... 3163